NEW YORK, NY--(Marketwire - December 10, 2008) - China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that its operating subsidiary in China, Hebei Aoxing Pharmaceutical Group Company, Ltd., received a new production license from the China State Food and Drug Administration ("SFDA") for Paracetamol and Caffeine Tablets, a controlled substance regulated by the SFDA.
